I. Y. Bajin Et Al. , "Tyrosine Kinase Inhibitor Responses in Pediatric CML Patients: Hacettepe Experience," PEDIATRIC BLOOD & CANCER , vol.64, 2017
Bajin, I. Y. Et Al. 2017. Tyrosine Kinase Inhibitor Responses in Pediatric CML Patients: Hacettepe Experience. PEDIATRIC BLOOD & CANCER , vol.64 .
Bajin, I. Y., AYTAÇ, S. A., KUŞKONMAZ, B. B., ÜNAL, S., Okur, V., Cetinkaya, D., ... ÇETİN, M.(2017). Tyrosine Kinase Inhibitor Responses in Pediatric CML Patients: Hacettepe Experience. PEDIATRIC BLOOD & CANCER , vol.64.
Bajin, I. Et Al. "Tyrosine Kinase Inhibitor Responses in Pediatric CML Patients: Hacettepe Experience," PEDIATRIC BLOOD & CANCER , vol.64, 2017
Bajin, I. Y. Et Al. "Tyrosine Kinase Inhibitor Responses in Pediatric CML Patients: Hacettepe Experience." PEDIATRIC BLOOD & CANCER , vol.64, 2017
Bajin, I. Y. Et Al. (2017) . "Tyrosine Kinase Inhibitor Responses in Pediatric CML Patients: Hacettepe Experience." PEDIATRIC BLOOD & CANCER , vol.64.
@article{article, author={I. Yaman Bajin Et Al. }, title={Tyrosine Kinase Inhibitor Responses in Pediatric CML Patients: Hacettepe Experience}, journal={PEDIATRIC BLOOD & CANCER}, year=2017}